Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Interventions for the treatment of oral cancer: surgical treatment

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD006205Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 18 octubre 2006see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Salud oral

Copyright:
  1. Copyright © 2007 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Richard J Oliver

    Correspondencia a: Oral and Maxillofacial Surgery, Manchester, UK

    [email protected]

  • Jan E Clarkson

    Dental Health Services Research Unit, The Mackenzie Building, Dundee, UK

  • David Conway

    Glasgow Dental Hospital and School, University of Glasgow, Glasgow, UK

  • Anne‐Marie Glenny

    Cochrane Oral Health Group, MANDEC, Manchester, UK

  • Michaelina Macluskey

    University of Dundee, Dundee, UK

  • Susan Pavitt

    Cochrane Oral Health Group, School of Dentistry, The University of Manchester, Manchester, UK

  • Philip Sloan

    School of Dentistry, The University of Manchester, Manchester, UK

  • P anel The CSROC Expert

    Other

  • Helen V Worthington

    MANDEC, School of Dentistry, The University of Manchester, Manchester, UK

  • The CSROC Expert Panel

    Cochrane Oral Health Group, School of Dentistry, The University of Manchester, Manchester, UK

Contributions of authors

Richard Oliver (RO), Jan Clarkson (JC), Helen Worthington (HW), Anne‐Marie Glenny (AMG) and Emma Tavender (ET) conceived, designed and sought funding for the review.
RO and Susan Pavitt (SP) co‐ordinated the review, collected data and developed the search strategy.
RO, Michaelina Macluskey (MM), JC, Phil Sloan (PS), David Conway (DC), HW, AMG and SP plan to screen the titles and abstracts.
SP will organise retrieval of papers.
RO, MM, JC, PS, DC, HW, AMG and SP will screen retrieved papers against the inclusion criteria, appraise the quality of the papers, and extract data; additionally, some members of the Cochrane Systematic Reviews on Oral Cancer (CSROC) Expert Panel will assist in the data extraction process.
RO and MM will obtain and screen data on unpublished studies and additional data on published studies.
RO, SP and HW will enter data into RevMan, be responsible for data management for the review, and analyse the data.
RO, JC, HW and MM will interpret the data.
HW and AMG will provide a methodological perspective.
RO, JC, MM, PS and members of the CSROC Expert Panel will provide a clinical perspective.
JC and PS will provide a policy perspective.
RO and MM will write the review.
The CSROC Expert Panel will provide comment /assist in the final review development.

The CSROC Expert Panel comprises:
Baujat B, Humphris G, Hutchison I, O'Brien C, Pignon J‐P, Robertson G, Rogers S, Shah J, Slevin N, Soutar D, Tavender E, Vermorken JB, Wardell S, Warnakulasuriya S, Webster K.

Sources of support

Internal sources

  • School of Dentistry, The University of Manchester, UK.

  • Cochrane Oral Health Group, UK.

  • The University of Dundee, UK.

  • The University of Glasgow, UK.

External sources

  • National Institute of Health, National Institute of Dental & Craniofacial Research, USA.

  • Central Manchester & Manchester Children's University Hospitals NHS Trust, UK.

Declarations of interest

None known.

Version history

Published

Title

Stage

Authors

Version

2023 Aug 31

Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatment

Review

Helen V Worthington, Vishal M Bulsara, Anne-Marie Glenny, Janet E Clarkson, David I Conway, Michaelina Macluskey

https://doi.org/10.1002/14651858.CD006205.pub5

2018 Dec 24

Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment

Review

Vishal M Bulsara, Helen V Worthington, Anne‐Marie Glenny, Janet E Clarkson, David I Conway, Michaelina Macluskey

https://doi.org/10.1002/14651858.CD006205.pub4

2011 Sep 07

Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment

Review

Alyson Bessell, Anne‐Marie Glenny, Susan Furness, Jan E Clarkson, Richard Oliver, David I Conway, Michaelina Macluskey, Sue Pavitt, Philip Sloan, Helen V Worthington

https://doi.org/10.1002/14651858.CD006205.pub3

2007 Oct 17

Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment

Review

Richard Oliver, Jan E Clarkson, David Conway, Anne‐Marie Glenny, Michaelina Macluskey, Sue Pavitt, Philip Sloan, The CSROC Expert Panel, Helen V Worthington

https://doi.org/10.1002/14651858.CD006205.pub2

2006 Oct 18

Interventions for the treatment of oral cancer: surgical treatment

Protocol

Richard J Oliver, Jan E Clarkson, David Conway, Anne‐Marie Glenny, Michaelina Macluskey, Susan Pavitt, Philip Sloan, P anel The CSROC Expert, Helen V Worthington, The CSROC Expert Panel

https://doi.org/10.1002/14651858.CD006205

Keywords

MeSH

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Table 1. MEDLINE, OLDMEDLINE, AMED search strategy

Form: (oral cancer) and (interventions) and (RCT filter, part 1 only)

Database: Ovid MEDLINE(R) In‐Process, Other Non‐Indexed Citations, Ovid MEDLINE(R), OLDMEDLINE(R), AMED(R).
Search strategy:
‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐
1 ((cancer$ or tumor$ or tumour$ or neoplas$ or malignan$ or carcinoma$ or metasta$) adj5 (oral$ or intra‐oral$ or gingiva$ or oropharyn$ or mouth$ or tongue$ or cheek or cheeks or gum or gums or palatal or palate or intraoral or (head adj2 neck))).mp.
2 "head and neck neoplasms"/ or mouth neoplasms/ or gingival neoplasms/ or palatal neoplasms/ or tongue neoplasms/
3 1 or 2
4 palliative.mp.
5 chemoradiotherap$.mp.
6 surg$.mp.
7 radiotherap$.mp.
8 chemotherap$.mp.
9 (neck adj1 dissection$).mp.
10 brachytherap$.mp.
11 (adjuvant or neo‐adjuvant).mp.
12 photodynamic.mp.
13 teletherap$.mp.
14 plesiotherap$.mp.
15 excision$.mp.
16 excise$.mp.
17 (hyperfractionate$ or hyper‐fractionate$).mp.
18 dahanca.mp.
19 arcon.mp.
20 radiat$.mp.
21 irradiat$.mp.
22 resect$.mp.
23 lymphadenectom$.mp.
24 curett$.mp.
25 neoadjuvant.mp.
26 glossectom$.mp.
27 antineoplas$.mp.
28 ((alternative or combined or gene or genetic or nutrition$) adj2 (therapy or therapies)).mp.
29 (onyx‐015 or amifostine$ or misonidazole$ or erythropoietin$).mp.
30 fluorouracil$.mp.
31 5‐fluorouracil$.mp.
32 cisplatin$.mp.
33 paclitaxel$.mp.
34 vinblastine$.mp.
35 bleomycin$.mp.
36 5fu.mp.
37 adriamycin$.mp.
38 doxorubicin$.mp.
39 methotrexa$.mp.
40 docetaxel$.mp.
41 carboplatin$.mp.
42 hydroxyurea.mp.
43 ((vitamin or nutrition$) adj2 supplement$).mp.
44 (herb or herbs).mp.
45 herbal.mp.
46 (locoregional$ adj5 (recurren$ or control$ or treat$ or lymph$)).mp.
47 aromatherap$.mp.
48 homeopath$.mp.
49 surg$.mp.
50 surg$.mp.
51 osteopath$.mp.
52 naturopath$.mp.
53 (wholistic or holistic).mp.
54 reflexolog$.mp.
55 massage$.mp.
56 (essential adj1 oil$).mp.
57 exp Radiotherapy/
58 exp Antineoplastic Agents/
59 exp surgical procedures, operative/ or lymph node excision/
60 exp Antimetabolites/
61 exp nursing care/ or palliative care/ or perioperative care/ or terminal care/
62 exp combined modality therapy/ or exp complementary therapies/ or exp nutrition therapy/ or exp rehabilitation/ or exp remission induction/ or exp salvage therapy/
63 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22
64 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42
65 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62
66 63 or 64 or 65
67 randomized controlled trial.pt.
68 controlled clinical trial.pt.
69 Randomized Controlled Trials/
70 Random Allocation/
71 Double‐Blind Method/
72 Single‐Blind Method/
73 or/67‐72
74 Animal/ not Human/
75 73 not 74
76 3 and 66 and 75

Figuras y tablas -
Table 1. MEDLINE, OLDMEDLINE, AMED search strategy
Table 2. EMBASE search strategy

Form: (oral cancer) and (interventions) and (RCT filter)

Database: EMBASE (from 1980 to present)
Search strategy:
‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐
1 "head and neck tumor"/ or "head and neck cancer"/ or mouth cancer/ or mouth carcinoma/ or oropharynx cancer/ or oropharynx carcinoma/ or tongue cancer/ or tongue carcinoma/ or tonsil cancer/ or tonsil carcinoma/ or mouth tumor/ or oropharynx tumor/ or tongue tumor/ or tonsil tumor/
2 ((cancer$ or tumor$ or tumour$ or neoplas$ or malignan$ or carcinoma$ or metasta$) adj5 ((oral$ not "Oral Drug Administration") or (intra‐oral$ or gingiva$ or oropharyn$ or mouth$ or tongue$ or cheek or cheeks or gum or gums or palatal or palate or intraoral or (head adj2 neck)))).mp.
3 1 or 2
4 palliative.mp.
5 chemoradiotherap$.mp.
6 surg$.mp.
7 radiotherap$.mp.
8 chemotherap$.mp.
9 (neck adj1 dissection$).mp.
10 brachytherap$.mp.
11 (adjuvant or neo‐adjuvant).mp.
12 photodynamic.mp.
13 teletherap$.mp.
14 plesiotherap$.mp.
15 (excision$ or excise$).mp.
16 (amifostine$ or misonidazole$ or erythropoietin$).mp.
17 (hyperfractionate$ or hyper‐fractionate$).mp.
18 dahanca.mp.
19 arcon.mp.
20 radiat$.mp.
21 irradiat$.mp.
22 resect$.mp.
23 lymphadenectom$.mp.
24 curett$.mp.
25 neoadjuvant.mp.
26 glossectom$.mp.
27 antineoplas$.mp.
28 ((alternative or combined or gene or genetic or nutrition$) adj2 (therapy or therapies)).mp.
29 onyx‐015.mp.
30 fluorouracil$.mp.
31 5‐fluorouracil$.mp.
32 cisplatin$.mp.
33 paclitaxel$.mp.
34 vinblastine$.mp.
35 bleomycin$.mp.
36 5fu.mp.
37 adriamycin$.mp.
38 doxorubicin$.mp.
39 methotrexa$.mp.
40 docetaxel$.mp.
41 carboplatin$.mp.
42 hydroxyurea.mp.
43 ((vitamin or nutrition$) adj2 supplement$).mp.
44 (herb or herbs).mp.
45 herbal.mp.
46 (locoregional$ adj5 (recurren$ or control$ or treat$ or lymph$)).mp.
47 aromatherap$.mp.
48 homeopath$.mp.
49 osteopath$.mp.
50 naturopath$.mp.
51 (wholistic or holistic).mp.
52 reflexolog$.mp.
53 massage$.mp.
54 (essential adj1 oil$).mp.
55 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22
56 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42
57 exp therapy/
58 surgery/ or exp cancer surgery/ or "head and neck surgery"/ or oral surgery/ or glossectomy/ or mandible osteotomy/ or mandible reconstruction/ or mandible resection/ or maxilla osteotomy/ or maxilla resection/ or palatoplasty/ or uvulopalatopharyngoplasty/ or surgical technique/ or anastomosis/ or electrosurgery/ or endoscopic surgery/ or excision/ or implantation/ or incision/ or laser surgery/ or ligation/ or microsurgery/ or myotomy/ or radiosurgery/ or surgical drainage/ or suture/
59 terminal care/
60 alternative medicine/
61 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60
62 random$.ti,ab.
63 factorial$.ti,ab.
64 placebo$.ti,ab.
65 (doubl$ adj blind$).ti,ab.
66 (singl$ adj blind$).ti,ab.
67 assign$.ti,ab.
68 allocat$.ti,ab.
69 volunteer$.ti,ab.
70 double‐blind procedure.sh.
71 randomized controlled trial.sh.
72 single blind procedure.sh.
73 62 or 63 or 64 or 65 or 66 or 67 or 68 or 69 or 70 or 71 or 72
74 animal/ or nonhuman/ or animal experiment/
75 human/
76 75 and 74
77 74 not 76
78 73 not 77
79 3 and 61 and 78

Figuras y tablas -
Table 2. EMBASE search strategy
Table 3. CENTRAL search strategy

Form: (interventions) and (oral cancer)

(palliative or chemoradiotherap* or surg* or radiotherap* or chemotherap* or brachytherap*)
(neck next dissection*)
(adjuvant or neo‐adjuvant or neoadjuvant)
(photodynamic or teletherap* or plesiotherap* or excision* or excise* or hyperfractionate* or hyper‐fractionate*)
(dahanca or arcon or radiat* or irradiat*)
(resect* or lymphadenectom* or curett* or glossectom* or antineoplas*)
(retroviral or retro‐viral)
(alternative or combined or gene or genetic or nutrition*)
(therapy or therapies)
(#8 and #9)
onyx‐015 or amifostine* or misonidazole* or erythropoietin*
(fluorouracil* or 5‐fluorouracil*)
(cisplatin* or paclitaxel* or vinblastine* or bleomycin* or 5fu or adriamycin* or doxorubicin* or methotrexa* or docetaxel* or carboplatin* or hydroxyurea)
(vitamin next supplement*)
(nutrition next supplement*)
(herb or herbs or herbal)
(locoregional* near recurren*)
(locoregional* near treatment)
(locoregional* near treatments)
(locoregional* near lymph*)
(aromatherap* or homeopath* or osteopath* or naturopath* or wholistic or holistic or reflexolog* or massage*)
(essential next oil*)
RADIOTHERAPY
ANTINEOPLASTIC AGENTS
SURGICAL PROCEDURES OPERATIVE
LYMPH
LYMPH NODE EXCISION
ANTIMETABOLITES
NURSING CARE
PALLIATIVE CARE
PERIOPERATIVE CARE
TERMINAL CARE
COMBINED MODALITY THERAPY
COMPLEMENTARY THERAPIES
NUTRITION THERAPY
REHABILITATION
REMISSION INDUCTION
SALVAGE THERAPY
(#1 or #2 or #3 or #4 or #5 or #6 or #7 or #10)
(#11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20)
(#21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30)
(#31 or #32 or #33 or #34 or #35 or #36 or #37 or #38)
(#39 or #40 or #41 or #42)
#43
(head near neck near cancer*)
(head near neck near tumor*)
(head near neck near tumour*)
(head near neck near neoplas*)
(head near neck near malignan*)
(head near neck near carcinoma*)
(head near neck near metasta*)
(#45 or #46 or #47 or #48 or #49 or #50 or #51)
(oral* near cancer*)
(oral* near tumor*)
(oral* near tumour*)
(oral* near neoplasm*)
(oral* near neoplas*)
(oral* near malignan*)
(oral* near carcinoma*)
(oral* near metasta*)
(intra‐oral* near cancer*)
(intra‐oral* near tumor*)
(intra‐oral* near tumour*)
(intra‐oral* near neoplas*)
(intra‐oral* near malignan*)
(intra‐oral* near carcinoma*)
(intra‐oral* near metasta*)
(gingiva* near metasta*)
(gingiva* near carcinoma*)
(gingiva* near malignan*)
(gingiva* near neoplas*)
(gingiva* near tumour*)
(gingiva* near tumor*)
(gingiva* near cancer*)
(oropharyn* near cancer*)
(oropharyn* near tumour*)
(oropharyn* near tumor*)
(oropharyn* near neoplas*)
(oropharyn* near malignan*)
(oropharyn* near carcinoma*)
(oropharyn* near metasta*)
(mouth* near metasta*)
(mouth* near carcinoma*)
(mouth* near malignan*)
(mouth* near neoplas*)
(mouth* near tumour*)
(mouth* near tumor*)
(mouth* near cancer*)
(tongue* near cancer*)
(tongue* near tumour*)
(tongue* near tumor*)
(tongue* near neoplas*)
(tongue* near malignan*)
(tongue* near carcinoma*)
(tongue* near metasta*)
(cheek* near metasta*)
(cheek* near carcinoma*)
(cheek* near malignan*)
(cheek* near neoplas*)
(cheek* near tumor*)
(cheek* near tumour*)
(cheek* near cancer*)
(gum near cancer*)
(gum near tumor*)
(gum near tumour*)
(gum near neoplas*)
(gum near malignan*)
(gum near carcinoma*)
(gum near metasta*)
(gums near metasta*)
(gums near carcinoma*)
(gums near malignan*)
(gums near neoplas*)
(gums near tumor*)
(gums near tumour*)
(gums near cancer*)
(palat* near cancer*)
(palat* near tumor*)
(palat* near tumour*)
(palat* near neoplas*)
(palat* near malignan*)
(palat* near carcinoma*)
(palat* near metasta*)
(intraoral* near metasta*)
(intraoral* near carcinoma*)
(intraoral* near malignan*)
(intraoral* near neoplas*)
(intraoral* near tumor*)
(intraoral* near tumour*)
(intraoral* near cancer*)
HEAD AND NECK NEOPLASMS
MOUTH NEOPLASMS
GINGIVAL NEOPLASMS
PALATAL NEOPLASMS
TONGUE NEOPLASMS
(#52 or #53 or #54 or #55 or #56 or #57 or #58 or #59)
(#60 or #61 or #62 or #63 or #64 or #65 or #66 or #67 or #68 or #69)
(#70 or #71 or #72 or #73 or #74 or #75 or #76 or #77 or #78 or #79)
(#80 or #81 or #82 or #83 or #84 or #85 or #86 or #87 or #88 or #89)
(#90 or #91 or #92 or #93 or #94 or #95 or #96 or #97 or #98 or #99)
(#100 or #101 or #102 or #103 or #104 or #105 or #106 or #107 or #108 or #109)
(#110 or #111 or #112 or #113 or #114 or #115 or #116 or #117 or #118 or #119)
(#120 or #121 or #122 or #123 or #124 or #125 or #126 or #127 or #128 or #129)
(#130 or #131 or #132 or #133 or #134 or #135 or #136 or #137 or #138 or #139)
(#140 or #141 or #142 or #143 or #144)
(#145 and #43)

Figuras y tablas -
Table 3. CENTRAL search strategy
Table 4. Summary of inclusion and exclusion criteria

Inclusion criteria

Exclusion criteria

Primary oral cancer

Lip

Squamous cell carcinoma (SCC)

Salivary gland malignancies

Histological variants of SCC

Nasopharyngeal cancer

Randomised controlled trials

Hypopharynx, nasopharynx and larynx

Primary and secondary outcomes included

Sarcomas and lymphomas

Surgical treatment of the primary tumour

Odontogenic tumours

Surgical management of the cervical lymph nodes when combined with surgical management of the primary tumour

Figuras y tablas -
Table 4. Summary of inclusion and exclusion criteria